Assessment of the impact of male factor infertility on the outcomes of assisted reproductive technology programs using machine learning techniques

Drapkina Yu.S., Makarova N.P., Kulakova E.V., Kalinina E.A.

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, Moscow, Russia

Background: The interpretation of spermogram parameters in dynamic observation remains debatable, and investigation of the significance and impact of some parameters on the effectiveness of infertility treatment using assisted reproductive technologies (ART) under the circumstances of increasing rate of male factor infertility is extremely relevant. Data analysis using machine learning (ML) enables more accurate and targeted determination of most significant correctable and non-correctable predictors of pregnancy after using ART programs.
Objective: The purpose of the study was determination of the significance and impact of each parameter characterizing the quality of the ejaculate on pregnancy rate, as well as the impact of these indicators on the embryonic stage of ART programs using linear regression and machine learning techniques.
Materials and methods: The retrospective study included 1021 married couples. The study analyzed spermogram data on the day of transvaginal ovarian puncture depending on the clinical and embryological outcomes in ART programs using decision tree and linear regression algorithms.
Results: The analysis of linear regression and decision tree models showed different results of the significance of each factors of  spermogram in determining the outcomes of the embryonic stage and pregnancy rate. It is noteworthy that the decision tree demonstrated high significance of the indicator “sperm concentration in 1 ml, mln”.
Conclusion: The results of the study reflect not only perspectives for further research in this area, but also the need to optimize the readiness of men for ART programs. Linear regression models not always capture hidden trends in the large volume of the analyzed information.

Authors' contributions: Drapkina Yu.S. – writing the text of the article, collecting literary data, processing the material; Makarova N.P. – study concept and design, editing the text of the article; Kulakova E.V., Kalinina E.A. – editing the text of the article.
Conflicts of interest: The authors confirm that they have no conflict of interest to declare.
Funding: The study was conducted without attraction of the third-party financing.
Ethical Approval: The study was approved by the local Ethics Committee of the Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia.
Patient Consent for Publication: The patients have signed informed consent for publication of their data.
Authors' Data Sharing Statement: The data supporting the findings of this study are available on request from the corresponding author after approval from the principal investigator.
For citation: Drapkina Yu.S., Makarova N.P., Kulakova E.V., Kalinina E.A. Assessment of the impact of  male factor infertility on the outcomes of assisted reproductive technology programs using machine learning techniques.
Akusherstvo i Gynecologia/Obstetrics and Gynecology. 2024; (7): 96-105 (in Russian)
https://dx.doi.org/10.18565/aig.2024.44

Keywords

artificial intelligence
ART
machine learning
spermogram
male infertility
decision tree
pregnancy rate

According to the Federal Service for State Statistics, since 2016 there is a high natural population decline and the birth rate decline in Russia [1, 2]. One of the most effective and current ways to overcome infertility and improve the demographic situation is using assisted reproductive technology (ART) programs. Since 2013, implementing ART programs has become possible at the expense of compulsory health insurance (CHI), that has become an additional positive incentive to increase the access to infertility treatment in various regions of Russia [3, 4]. The structure of infertility in married couple is largely region-specific [5]. For example, the maximum frequency of male reproductive health disorders per 100 thousand male population is observed in the North Caucasian and Ural Federal Districts, where their rate is 3 times higher than the national average rate. On the contrary, in the Far Eastern Federal District, the rate of male infertility is 3 times lower than the average rate in the Russian Federation [6].

It is noted that the number of patients who seek infertility treatment at an older reproductive age has been increasing over the last years [7]. It is generally accepted that one of the determining factors that influences the effectiveness of ART is the age of women, while on the contrary, men are able to remain fertile for many years. However, it should be noted that with age there is a decline in testosterone levels and the parameters of spermatogenesis in men, and the frequency of miscarriages in their female partners increases. There is an increased number of de novo mutations in sperm (4–5% growth annually), and chromosomal aneuploidies occur more often [8]. Interpretation of spermogram parameters in men during dynamic observation can also be ambiguous; the significance and influence of some parameters on the effectiveness of ART treatment remains controversial.  Danis R.B. et al. reported that assessment of fertility potential using spermogram parameters varies greatly, and identification of the most significant parameter to predict natural pregnancy or using ART remains uncertain. Also, the study showed that determination of the percentage of morphologically healthy sperm in the ejaculate has a low predictive value [9].

To reconstruct relationship between certain characteristics of the ejaculate using a large set of different parameters for obtaining not only the prognosis of treatment effect using ART, but also identification of the most significant factors that determine the resulting prediction, a large number of mathematical models have been proposed, including the use of artificial intelligence (AI) and machine learning (ML). ML enables to specify the algorithms for input data and the use of statistical analysis to predict output information in the process of emergence of new data. One of the promising research areas in ML and male factor infertility is the use of AI to predict blastulation rate, embryo quality and the outcome of infertility treatment using ART [10]. You J.B. et al. reported that from the practical point of view, optimization of sperm selection using ML to improve the effectiveness of ART programs, seems to be an urgent task. However, the issue of interpreting the most important spermogram parameters for the use of their values ​​to build accurate predictive models using ML, remains controversial [11].

It should be noted that the classical mathematical models cannot automatically select the optimal characteristics, and the researcher decides independently according to his point of view to select the most significant characteristics for model building. In addition, if there are nonlinear relationships, the model cannot be able to capture the nonlinearity. Given the presence of both categorical and quantitative data in the spermogram available for analysis, the likelihood of nonlinearity is extremely high. Thus, the use of ML-based systems makes it possible to process complex dependencies that are resistant to noise, and obtain good indicators of data generalization and highlight the most significant characteristics [12]. Moreover, the analyzed information can be processed in the presence of information imperfections or incomplete data to obtain comparable predictive ability. Given the fact that the study of influence of various spermogram parameters on prediction of treatment outcomes seems extremely relevant in terms of optimization of preparation of men for IVF cycle, the purpose of this study was to determine the significance and influence of each parameter characterizing the quality of the ejaculate on pregnancy rate, as well as the influence of these parameters on the embryonic stage of ART programs using linear regression and ML.

Material and methods

The retrospective study included 1021 married couples ages 21–40 years, who sought infertility treatment using ART. Written informed consent was obtained from each couple to process their personal data.  Inclusion criteria in the study were infertility caused by tubo-peritoneal, male or combined factors, chronic anovulation or diminished ovarian reserve, as well as normal karyotype of the spouses, ovarian stimulation according to the protocol with a gonadotropin releasing hormone (GnRH) antagonist, the standard protocol of luteal phase support after embryo transfer, obtaining the patients’ oocytes on the day of transvaginal puncture (TVP), single-embryo transfer. Exclusion criteria included abnormalities of the uterus, abnormal karyotype, and the use of donor oocytes or sperm.

The patients participating in the study underwent ovarian stimulation according to the protocol of GnRH antagonist administration from day 2 or 3 of the menstrual cycle. When the follicle reached ≥17 mm in diameter, HCG was administered to patients to trigger final oocyte maturation (800 patients), or in case of risk of ovarian hyperstimulation syndrome, the trigger was replaced with GnRH agonist (138 patients), or dual trigger was used for final oocyte maturation (83 patients). Transvaginal follicle puncture (TFP) was performed 35–36 hours after triggering ovulation, followed by oocyte collection and assessment of oocyte quality. Subsequently, fertilization of the obtained oocytes was done using in vitro fertilization (IVF) (5.6% of patients), intracytoplasmic sperm injection (ICSI) into an oocyte (81.9%) and physiological ICSI (PIXI) (12.5%). High fertilization rate after the ICSI procedure was associated with lower spermogram values on the day of TFP. All stages of culturing were done in COOK multi-gas incubators (Ireland) in 25 μl drops of culture media under oil (Irvine Sc., USA) at Prof. B.V. Leonov Department of Assisted Technologies in Infertility Treatment, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology. On day 5 after fertilization, the embryo was transferred into the uterine cavity using soft Wallace catheter (Germany) or Cook catheter (Australia). The remaining embryos of appropriate quality were cryopreserved for further use in cryoprotocol. Standard luteal phase support and managing the care of patients after embryo transfer was provided. On day 14 after embryo transfer, beta subunit human chorionic gonadotropin (beta-HCG) levels were evaluated. When beta- hCG levels were positive, 21 days after embryo transfer the patients underwent pelvic ultrasound to diagnose clinical pregnancy. Further management of pregnancy was carried out individually.

The study analyzed the number of the best-quality, good-quality and average-quality blastocysts, the number of embryos that stopped developing, the morphological assessment of embryo quality using Gardner's embryo grading system, the frequency of clinical pregnancy depending on spermogram parameters on the day of TFP (sperm concentration, the percentage of progressive motility and non-progressive motility, sperm immotility and morphologically healthy sperm).

Statistical data processing and the algorithm for building decision tree

Microsoft Excel, version 15.0 with appropriate license was used for statistical analysis of the obtained data. The ShapiroWilk test was used to check the normality of the sample. In interpreting statistical analysis results, the significance level of p-value equal to 0.05 was considered to be critical. Multivariate analysis was used to analyze datasets in all models in the study. Dependent variables (response variables, that is, the characteristics, which were influenced by independent variables) and independent variables (which are represented as “Characteristics” in the Tables, section “Results”) were used in regression analysis. The applicability of linear regression analysis was checked. The normality of distribution of residuals and the equality of their variances were checked, and only uncorrelated features were selected. The Pearson correlation coefficient was used for testing non-correlation. Regression equation is the following:

 =

where b –  the parameters of the model;

References

  1. Zegers-Hochschild F., Adamson G.D., Dyer S., Racowsky C., de Mouzon J., Sokol R. et al. The international glossary on infertility and fertility care, 2017. Fertil. Steril. 2017; 108(3): 393-406. https://dx.doi.org/10.1016/ j.fertnstert.2017.06.005.
  2. Vander Borght M., Wyns C. Fertility and infertility: definition and epidemiology. Clin. Biochem. 2018; 62: 2-10. https://dx.doi.org/10.1016/ j.clinbiochem.2018.03.012.
  3. Приказ Министерства здравоохранения Российской Федерации N 108н от 28.02.2019 «Об утверждении правил обязательного медицинского страхования» (с изменениями 13.12.2022 №789н). [Order of the Ministry of Health of the Russian Federation No. 108n dated 28.02.2019 "On approval of the rules of compulsory health insurance" (as amended 13.12.2022 No.789n). (in Russian)].
  4. Приказ Министерства здравоохранения Российской Федерации от 31 июля 2020 г. № 803н «О порядке использования вспомогательных репродуктивных технологий, противопоказаниях и ограничениях к их применению». [Order of the Ministry of Health of the Russian Federation of July 31, 2020 No. 803n "On the procedure for using assisted reproductive technologies, contraindications and restrictions on their use". (in Russian)].
  5. Корнеева И.Е., Назаренко Т.А., Перминова С.Г., Митюрина Е.В., Цыбизова Т.И., Дашиева А.Э. Медико-социальные факторы бесплодия в России. Акушерство и гинекология. 2023; 3: 65-72. [Korneeva I.Е., Nazarenko Т.А., Perminova S.G., Mityurina E.V., Tsybizova T.I., Dashieva A.E. Medical and social factors of infertility in Russia. Obstetrics and Gynecology. 2023; (3): 65-72. (in Russian)]. https://dx.doi.org/10.18565/aig.2022.279.
  6. Лебедев Г.С., Голубев Н.А., Шадеркин И.А., Шадеркина В.А., Аполихин О.И., Сивков А.В., Комарова В.А. Мужское бесплодие в Российской Федерации: статистические данные за 2000-2018 годы. Экспериментальная и клиническая урология. 2019; 4: 4-12. [Lebedev G.S., Golubev N.A., Shaderkin I.A., Shaderkina V.A., Apolikhin O.I., Sivkov A.V., Komarova V.A. Male infertility in the Russian Federation: statistical data for 2000-2018. Experimental and Clinical Urology. 2019; (4): 4-12. (in Russian)]. https://dx.doi.org/10.29188/ 2222-8543-2019-11-4-4-12.
  7. Шатылко Т.В., Гамидов С.И., Франкевич В.Е., Стародубцева Н.Л., Гасанов Н.Г., Тамбиев А.Х. Астенозооспермия и протеомные факторы регуляции подвижности сперматозоидов. Акушерство и гинекология. 2020; 4: 37-44. [Shatylko T.V., Gamidov S.I., Frankevich V.E., Starodubtseva N.L., Gasanov N.G., Tambiev A.Kh. Asthenozoospermia and proteomic factors regulating sperm motility.Obstetrics and Gynecology. 2020; (4): 37-44.(in Russian)]. https://dx.doi.org/10.18565/aig.2020.4.37-44.
  8. Овчинников Р.И., Гамидов С.И., Попова А.Ю., Ушакова И.В., Голубева О.Н. Привычное невынашивание беременности - что зависит от мужчины? Акушерство и гинекология. 2016; 12: 15-23. [Ovchinnikov R.I., Gamidov S.I., Popova A.Yu., Ushakova I.V., Golubeva O.N. Recurrent miscarriage: what depends on a male partner? Obstetrics and Gynecology. 2016; (12): 15-23. (in Russian)]. https://dx.doi.org/10.18565/aig.2016.12.15-23.
  9. Danis R.B., Samplaski M.K. Sperm morphology: history, challenges, and impact on natural and assisted fertility. Curr. Urol. Rep. 2019; 20(8): 43. https://dx.doi.org/10.1007/s11934-019-0911-7.
  10. Jiang V.S., Bormann C.L. Artificial intelligence in the in vitro fertilization laboratory: a review of advancements over the last decade. Fertil. Steril. 2023; 120(1): 17-23. https://dx.doi.org/10.1016/j.fertnstert.2023.05.149.
  11. You J.B., McCallum C., Wang Y., Riordon J, Nosrati R, Sinton D. Machine learning for sperm selection. Nat. Rev. Urol. 2021; 18(7): 387-403. https://dx.doi.org/10.1038/s41585-021-00465-1.
  12. Choi R.Y., Coyner A.S., Kalpathy-Cramer J., Chiang M.F., Campbell J.P. Introduction to machine learning, neural networks, and deep learning. Transl. Vis. Sci. Technol. 2020; 9(2): 14. https://dx.doi.org/10.1167/tvst.9.2.14.
  13. Драпкина Ю.С., Макарова Н.П., Татаурова П.Д., Калинина Е.А. Поддержка врачебных решений с помощью глубокого машинного обучения при лечении бесплодия методами вспомогательных репродуктивных технологий. Медицинский совет. 2023; 17(15): 27-37. [Drapkina Yu.S., Makarova N.Р., Tataurova P.D., Kalinina E.A. Deep machine learning applied to support clinical decision-making in the treatment of infertility using assisted reproductive technologies. Medical Council. 2023; 17(15): 27-37. (in Russian)]. https://dx.doi.org/10.21518/ms2023-368.
  14. Олефир Ю.В., Виноградов И.В., Родионов М.А., Живулько А.Р., Попов Д.М., Монаков Д.М. Шестое руководство ВОЗ по обработке и исследованию эякулята: все новое - это хорошо забытое старое? Вестник урологии. 2023; 11(1): 171-6. [Olefir Yu.V., Vinogradov I.V., Rodionov M.A., Zhyvul’ko A.R., Popov D.M., Monakov D.M. The sixth edition of the WHO laboratory manual for the examination and processing of human semen: is everything new a well-forgotten old? Urology Herald. 2023; 11(1): 171-6. (in Russian)].https://dx.doi.org/10.21886/2308-6424-2023-11-1-171-176.
  15. Cooper T.G., Noonan E., von Eckardstein S., Auger J., Baker H.W., Behre H.M. et al. World Health Organization reference values for human semen characteristics. Hum. Reprod. Update. 2010; 16(3): 231-45. https://dx.doi.org/10.1093/humupd/dmp048.
  16. Chua A.C., Abdul Karim A.K., Tan A.C.C., Abu M.A., Ahmad M.F. The outcome of intra-cytoplasmic sperm injection (ICSI): do the sperm concentration and motility matter? Horm. Mol. Biol. Clin. Investig. 2021; 42(4): 367-72. https://dx.doi.org/10.1515/hmbci-2020-0089.
  17. Timofeeva A., Drapkina Y., Fedorov I., Chagovets V., Makarova N., Shamina M. et al. Small noncoding RNA signatures for determining the developmental potential of an embryo at the morula stage. Int. J. Mol. Sci. 2020; 21(24): 9399. https://dx.doi.org/10.3390/ijms21249399.
  18. Nagy Z.P., Liu J., Joris H., Verheyen G., Tournaye H., Camus M. et al. The result of intracytoplasmic sperm injection is not related to any of the three basic sperm parameters. Hum. Reprod. 1995; 10(5): 1123-9. https://dx.doi.org/10.1093/oxfordjournals.humrep.a136104.
  19. Tannus S., Son W.Y., Gilman A., Younes G., Shavit T., Dahan M.H. The role of intracytoplasmic sperm injection in non-male factor infertility in advanced maternal age. Hum. Reprod. 2017; 32(1): 119-24. https://dx.doi.org/10.1093/humrep/dew298.
  20. Mercan R., Lanzendorf E.S., Mayer J. Jr, Nassar A., Muasher S.J., Oehninger S. The outcome of clinical pregnancies following intracytoplasmic sperm injection is not affected by semen quality. Andrologia. 1998; 30(2): 91-5.https://dx.doi.org/10.1111/j.1439-0272.1998.tb01152.x.
  21. Zaninovic N., Rosenwaks Z. Artificial intelligence in human in vitro fertilization and embryology. Fertil. Steril. 2020; 114(5): 914-20.https://dx.doi.org/10.1016/j.fertnstert.2020.09.157.
  22. Goyal A., Kuchana M., Ayyagari K.P.R. Machine learning predicts live-birth occurrence before in-vitro fertilization treatment. Sci. Rep. 2020; 10(1): 20925. https://dx.doi.org/10.1038/s41598-020-76928-z.
  23. Peng T., Liao C., Ye X., Chen Z., Li X., Lan Y. et al. Machine learning-based clustering to identify the combined effect of the DNA fragmentation index and conventional semen parameters on in vitro fertilization outcomes. Reprod. Biol. Endocrinol. 2023; 21(1): 26. https://dx.doi.org/10.1186/s12958-023-01080-y.

Received 01.03.2024

Accepted 03.06.2024

About the Authors

Yulia S. Drapkina, PhD, Researcher at the Department of IVF named after Prof. B.V. Leonov, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, 117997, Russia, Moscow, Academician Oparin str., 4, yu_drapkina@oparina4.ru,
https://orcid.org/0000-0002-0545-1607
Natalya P. Makarova, PhD, Leading Researcher at the Department of IVF named after Prof. B.V. Leonov, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, 117997, Russia, Moscow, Academician Oparin str., np_makarova@oparina4.ru,
https://orcid.org/0000-0003-8922-2878
Elena V. Kulakova, PhD, Senior Researcher at the IVF Department named after Prof. B.V. Leonov, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, 117997, Russia, Moscow, Academician Oparin str., 4, e_kulakova@oparina4.ru,
https://orcid.org/0000-0002-4433-4163
Elena A. Kalinina, Dr. Med. Sci., Professor, Head of the IVF Department named after Prof. B.V. Leonov, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, 117997, Russia, Moscow, Academician Oparin str., 4, e_kalinina@oparina4.ru,
https://orcid.org/0000-0002-8922-2878

Similar Articles

By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.